I. Eichler and E. Sala Soriano Close collaboration between academia, industry and drug regulators is required in the development of allergen products for specific immunotherapy in children Allergy 66
Article first published online: 23 MAR 2011 | DOI: 10.1111/j.1398-9995.2011.02582.x
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field
Choose captcha format: Image or Audio. Click here if you need help.